Key statistics
On Friday, Biontech SE (B1NT34:SAO) closed at 38.35, -21.81% below its 52-week high of 49.05, set on Jan 07, 2025.
52-week range
Open | 38.28 |
---|---|
High | 38.35 |
Low | 38.12 |
Bid | 37.38 |
Offer | 39.50 |
Previous close | 38.92 |
Average volume | 160.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jul 18 2025 19:45 BST.
More ▼
- BioNTech Announces Ryan Richardson to Step Down from the Management Board
- BioNTech gibt den Rücktritt von Ryan Richardson aus dem Vorstand bekannt
- EQS-News: GENUI sells labor team to Galenica
- EQS-News: Mallia Innovations: Mallia Appoints Jens Holstein, Dr. Alexandra Ogilvie, and Dr. Ulrich Dauer to its Advisory Board
- EQS-News: MIG Capital Announces €50 Million in Series A Funding for Look Up
- BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
- BioNTech kündigt strategische Transaktion zur Übernahme von CureVac im Rahmen eines öffentlichen Umtauschangebots an
- EQS-News: Mallia sets strategic course for future and completes €5.5 million financing
- BioNTech und Bristol Myers Squibb geben globale strategische Partnerschaft zur gemeinsamen Entwicklung und Kommerzialisierung des bispezifischen Antikörperkandidaten BNT327 in einer Vielzahl solider Tumorarten bekannt
- BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types
More ▼